Janet Hampton Explains the Distress Thermometer Study
Janet Hampton from the University of Michigan Health System Cancer Center Explains the Distress Thermometer Study
Janet Hampton on the Distress Thermometer Study Results
Janet Hampton University of Michigan Health System Cancer Center Explains Distress Thermometer Study Results
Janet Hampton Describes the Distress Thermometer
Durvalumab Garners Similar OS, Albeit Varied PFS, Outcomes in EGFR+ and EGFR-Wildtype NSCLC Subgroups
Quizartinib Extends Overall Survival Across Multiple Subgroups in FLT3-ITD+ AML
Repotrectinib Showcases Early Intracranial Responses in Select ROS1+ NSCLC
Osimertinib May Be More Effective in Frontline EGFR+ NSCLC When Combined With Chemo
